Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
T Cell Types and Functions01:24

T Cell Types and Functions

2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Restoration of Saccadic Eye Movements and Visually Guided Behavior in Ambient White Light with Photoswitchable Small Molecules.

Journal of the American Chemical Society·2026
Same author

Glomerular Injury Induced by Daily Exposure to the Low-Frequency Component of Environmental Noise via Endothelin Signaling in Mice.

Environmental science & technology·2026
Same author

Targeted Inhibition of mGlu5 Receptors in the Contralesional Hemisphere Improves Functional Recovery After Stroke.

Stroke·2026
Same author

Light-Regulated Agonists Spatiotemporally Activating the Vitamin D Receptor Mitigate Psoriasis-like Inflammation in Mice without Inducing Hypercalcemia.

ACS central science·2025
Same author

Sex Bias in IL-10 Production by Type I Regulatory T Cells Regulated by PI3K/mTOR Signaling.

Neurology(R) neuroimmunology & neuroinflammation·2025
Same author

Novae: a graph-based foundation model for spatial transcriptomics data.

Nature methods·2025

相关实验视频

Updated: Jan 18, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

8.0K

有条件的IL4I1非激活触发了与瘤相关的巨细胞重编程和CD8+T细胞的重新激活,以控制黑色素瘤的进展.

Malvina Seradj1, Saniya Kari1, Anna Llebaria-Fabrias1

  • 1Institut Cochin Paris France.

Cancer immunology research
|January 15, 2026
PubMed
概括

在瘤相关巨细胞 (TAMs) 中的酶IL-4诱导基因1 (IL4I1) 促进黑色素瘤免疫逃生. 抑制IL4I1可以增强抗瘤免疫力,并延缓黑色素瘤的进展,从而提供新的免疫疗法策略.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.9K
Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

10.2K

相关实验视频

Last Updated: Jan 18, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

8.0K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.9K
Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

10.2K

科学领域:

  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.
  • 生物化学 生物化学

背景情况:

  • 瘤相关巨细胞 (TAMs) 是癌症中的关键免疫细胞,通常与预后不佳有关.
  • 通过免疫抑制酶表达,TAMs可以通过免疫抑制酶表达来采用突瘤特性.
  • IL-4诱导基因1 (IL4I1) 是一种酶,涉及瘤微环境中的免疫调节.

研究的目的:

  • 调查TAMs表达的IL4I1在黑色素瘤进展中的作用.
  • 确定IL4I1对TAM功能和抗瘤免疫力的影响.
  • 探索IL4I1作为黑色素瘤免疫治疗中的潜在治疗点.

主要方法:

  • 在小鼠模型中分析TAMs中的IL4I1表达在自发黑色素瘤进展期间.
  • 在巨细胞中遗传删除IL4I1,以评估其对瘤生长和转移的体内影响.
  • 药理上阻断IL4I1活动.
  • 评估TAM抗原呈现能力和CD8+T细胞功能.

主要成果:

  • 在黑色素瘤进展期间,TAM子集中的IL4I1表达被上调,可通过细胞因子同中和控制.
  • 宏细胞特异性IL4I1删除显著延迟了瘤的发病和减少了转移性传播.
  • 向IL4I1增强了TAM抗原呈现,并恢复了CD8+ T细胞的增殖和细胞毒性.
  • 化学IL4I1阻断部分复制了这些抗瘤效应.

结论:

  • 在黑色素瘤中,IL4I1在TAM介导的免疫逃避中发挥着关键作用.
  • 抑制IL4I1是恢复黑色素瘤抗瘤免疫力的有希望的策略.
  • 针对TAM中的IL4I1具有促进癌症免疫疗法的潜力,特别是在IL4I1表达的人类瘤中.